Literature DB >> 32402083

Insights from ORION studies: focus on inclisiran safety.

Alberico Luigi Catapano1,2, Angela Pirillo2,3, Giuseppe Danilo Norata1,3.   

Abstract

Mesh：

Substances：

Year:  2021        PMID： 32402083     DOI： 10.1093/cvr/cvaa139

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN： 0008-6363            Impact factor:   10.787


× No keyword cloud information.
  1 in total

Review 1.  RNA Silencing in the Management of Dyslipidemias.

Authors:  Neil C Henney; Maciej Banach; Peter E Penson
Journal:  Curr Atheroscler Rep       Date:  2021-09-01       Impact factor: 5.113
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.